Delivery of medicinal products included in the List under Article 266a, Paragraph 2 of the Law on Medicinal Products in Human Medicine – Teduglutide

This tender concerns the procurement of a specific medicinal product, Teduglutide, which is listed under Article 266a, Paragraph 2 of the Law on Medicinal Products in Human Medicine. The contracting authority requires the delivery of this pharmaceutical product. The description reiterates the title, emphasizing that the product must be included in the aforementioned legal list. This implies a need for a highly regulated and specific medication, likely for patient treatment within a healthcare setting. The tender focuses solely on the supply of this particular drug, indicating a targeted procurement effort. Further details regarding quantities, delivery schedules, and specific quality standards would typically be found in the full tender documentation, but the core requirement is the provision of Teduglutide as per Bulgarian pharmaceutical legislation.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.